Genotype–Phenotype Relationships in a Large French Cohort of Subjects with Inherited Protein C Deficiency

Abstract

Inherited protein C (PC) deficiency caused by mutations in the PROC gene is a well-known risk factor for venous thromboembolism. Few studies have investigated the relationship between PROC genotype and plasma or clinical phenotypes. We addressed this issue in a large retrospective cohort of 1,115 heterozygous carriers of 226 PROC pathogenic or likely pathogenic mutations. Mutations were classified in three categories according to their observed or presumed association with type I, type IIa, or type IIb PC deficiency. The study population comprised 876 carriers of type I category mutations, 55 carriers of type IIa category mutations, and 184 carriers of type IIb category mutations. PC anticoagulant activity significantly influenced risk of first venous thrombosis (p trend < 10⁻⁴). No influence of mutation category on risk of whole or unprovoked thrombotic events was observed. Both PC anticoagulant activity and genotype significantly influenced risk of venous thrombosis. Effect of detrimental mutations on plasma phenotype was ambiguous in several carriers, whatever the mutation category. Altogether, our findings confirm that diagnosing PC inherited deficiency based on plasma measurement may be difficult but show that diagnosis can be improved by PROC genotyping.

Keywords

coagulation inhibitor - protein C - PROC - thrombophilia - thrombosis

Publikationsverlauf

Eingereicht: 20. Januar 2020

Angenommen: 30. Mai 2020

Artikel online veröffentlicht:
27. Juli 2020

• References

• 1 Stenflo J. Structure and function of protein C. Semin Thromb Hemost 1984; 10 (02) 109-121
• 2 Foster DC, Yoshitake S, Davie EW. The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A 1985; 82 (14) 4673-4677
• 3 Plutzky J, Hoskins JA, Long GL, Crabtree GR. Evolution and organization of the human protein C gene. Proc Natl Acad Sci U S A 1986; 83 (03) 546-550
• 4 Cooper PC, Hill M, Maclean RM. The phenotypic and genetic assessment of protein C deficiency. Int J Lab Hematol 2012; 34 (04) 336-346
• 5 Bereczky Z, Kovács KB, Muszbek L. Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game. Clin Chem Lab Med 2010; 48 (Suppl. 01) S53-S66
• 6 Di Minno MN, Ambrosino P, Ageno W, Rosendaal F, Di Minno G, Dentali F. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. Thromb Res 2015; 135 (05) 923-932
• 7 Picard V, Dautzenberg MD, Villoutreix BO, Orliaguet G, Alhenc-Gelas M, Aiach M. Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis. Blood 2003; 102 (03) 919-925
• 8 Richards S, Aziz N, Bale S. , et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 9 Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res 2003; 31 (13) 3812-3814
• 10 Adzhubei IA, Schmidt S, Peshkin L. , et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7 (04) 248-249
• 11 Salgado D, Desvignes J-P, Rai G. , et al. UMD-Predictor: a high throughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution. Hum Mutat 2016; 37 (05) 439-446
• 12 Houdayer C. In silico prediction of splice-affecting nucleotide variants. Methods Mol Biol 2011; 760: 269-281
• 13 Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; 31 (16) 2745-2747
• 14 Kopanos C, Tsiolkas V, Kouris A. , et al. VarSome: the human genomic variant search engine. Bioinformatics 2019; 35 (11) 1978-1980
• 15 Li Q, Wang K. InterVar: clinical interpretation of genetic variants by ACMG-AMP 2015 guideline. Am J Hum Genet 2017; 100: 1-14
• 16 Gandrille S, Alhenc-Gelas M, Gaussem P. , et al. Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activity. Blood 1993; 82 (01) 159-168
• 17 Reitsma PH, Bernardi F, Doig RG. , et al. Protein C deficiency: a database of mutations 1995 update. Thromb Haemost 1995; 73 (05) 876-889
• 18 Greengard JS, Griffin JH, Fisher CL. Possible structural implications of 20 mutations in the protein C protease domain. Thromb Haemost 1994; 72 (06) 869-873
• 19 Martos L, Fernández-Pardo Á, López-Fernández MF. , et al; Working Group of the Spanish Society of Thrombosis Haemostasis (SETH). Identification of 58 mutations (26 novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency. Thromb Haemost 2019; 119 (09) 1409-1418
• 20 Lu Y, Giri H, Villoutreix BO, Ding Q, Wang X, Rezaie AR. Gly197Arg mutation in protein C causes recurrent thrombosis in a heterozygous carrier. J Thromb Haemost 2020; 18 (05) 1141-1153
• 21 Preston RJ, Morse C, Murden SL, Brady SK, O'Donnell JS, Mumford AD. The protein C ω-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity. Br J Haematol 2009; 144 (06) 946-953
• 22 Ido M, Ohiwa M, Hayashi T. , et al. A compound heterozygous protein C deficiency with a single nucleotide G deletion encoding Gly-381 and an amino acid substitution of Lys for Gla-26. Thromb Haemost 1993; 70 (04) 636-641
• 23 Poort SR, Pabinger-Fasching I, Mannhalter C, Reitsma PH, Bertina RM. Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency. Blood Coagul Fibrinolysis 1993; 4 (02) 273-280
• 24 Liu H, Wang HF, Tang L. , et al. Compound heterozygous protein C deficiency in a family with venous thrombosis: identification and in vitro study of p.Asp297His and p.Val420Leu mutations. Gene 2015; 563 (01) 35-40
• 25 Rovida E, Merati G, D'Ursi P. , et al. Identification and computationally-based structural interpretation of naturally occurring variants of human protein C. Hum Mutat 2007; 28 (04) 345-355
• 26 Simioni P, Kalafatis M, Millar DS. , et al. Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma. Blood 1996; 88 (06) 2101-2108
• 27 Alhenc-Gelas M, Plu-Bureau G, Hugon-Rodin J, Picard V, Horellou MH. GFHT study group on Genetic Thrombophilia. Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency. Thromb Haemost 2017; 117 (06) 1040-1051
• 28 Pomp ER, Doggen CJM, Vos HL, Reitsma PH, Rosendaal FR. Polymorphisms in the protein C gene as risk factor for venous thrombosis. Thromb Haemost 2009; 101 (01) 62-67
• 29 Caspers M, Pavlova A, Driesen J. , et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. Thromb Haemost 2012; 108 (02) 247-257
• 30 Marlar RA, Gausman JN. Laboratory testing issues for protein C, protein S, and antithrombin. Int J Lab Hematol 2014; 36 (03) 289-295
• 31 Cooper PC, Pavlova A, Moore GW, Hickey KP, Marlar RA. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH. J Thromb Haemost 2020; 18 (02) 271-277
• 32 Folsom AR, Aleksic N, Wang L, Cushman M, Wu KK, White RH. Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study. Arterioscler Thromb Vasc Biol 2002; 22 (06) 1018-1022
• 33 Koster T, Rosendaal FR, Briët E. , et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85 (10) 2756-2761
• 34 Lowe G, Woodward M, Vessey M, Rumley A, Gough P, Daly E. Thrombotic variables and risk of idiopathic thromboembolism in women aged 45–64 years Relationships to hormone replacement therapy. Thromb Haemost 2000; 83 (04) 530-535
• 35 Bucciarelli P, Passamonti SM, Biguzzi E. , et al. Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism. J Thromb Haemost 2012; 10 (09) 1783-1791
• 36 Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341 (8838): 134-138
• 37 Tang W, Stimson MR, Basu S. , et al. Burden of rare exome sequence variants in PROC gene is associated with venous thromboembolism: a population-based study. J Thromb Haemost 2020; 18 (02) 445-453
• 38 Ding Q, Yang L, Dinarvand P, Wang X, Rezaie AR. Protein C Thr315Ala variant results in gain of function but manifests as type II deficiency in diagnostic assays. Blood 2015; 125 (15) 2428-2434
• 39 Steinkamp M, Geva A, Joffe S, Lapp CN, Neufeld EJ. Chronic disseminated intravascular coagulation and childhood-onset skin necrosis resulting from homozygosity for a protein C Gla domain mutation, Arg15Trp. J Pediatr Hematol Oncol 2002; 24 (08) 685-688
• 40 Ding Q, Yang L, Hassanian SM, Rezaie AR. Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population. Thromb Haemost 2013; 109 (04) 614-624
• 41 Rojnuckarin P, Settapiboon R, Akkawat B, Teocharoen S, Suksusut A, Uaprasert N. Natural anticoagulant deficiencies in Thais: a population-based study. Thromb Res 2019; 178: 7-11
• 42 Miyata T, Sakata T, Yasumuro Y. , et al. Genetic analysis of protein C deficiency in nineteen Japanese families: five recurrent defects can explain half of the deficiencies. Thromb Res 1998; 92 (04) 181-187
• 43 Greengard JS, Fisher CL, Villoutreix B, Griffin JH. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins 1994; 18 (04) 367-380
• 44 Tokunaga F, Tsukamoto T, Koide T. Cellular basis for protein C deficiency caused by a single amino acid substitution at Arg15 in the gamma-carboxyglutamic acid domain. J Biochem 1996; 120 (02) 360-368
• 45 Fidalgo T, Martinho P, Salvado R. , et al. Familial thrombotic risk based on the genetic background of protein C deficiency in a Portuguese study. Eur J Haematol 2015; 95 (04) 294-307
• 46 Souto JC, Almasy L, Borrell M. , et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000; 67 (06) 1452-1459
• 47 Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2004; 2 (08) 1305-1310
• 48 Pintao MC, Roshani S, de Visser MC. , et al. High levels of protein C are determined by PROCR haplotype 3. J Thromb Haemost 2011; 9 (05) 969-976
• 49 Baron JM, Johnson SM, Ledford-Kraemer MR, Hayward CP, Meijer P, Van Cott EM. Protein C assay performance: an analysis of North American specialized coagulation laboratory association proficiency testing results. Am J Clin Pathol 2012; 137 (06) 909-915
• 50 Cunningham MT, Olson JD, Chandler WL. , et al. External quality assurance of antithrombin, protein C, and protein s assays: results of the College of American Pathologists proficiency testing program in thrombophilia. Arch Pathol Lab Med 2011; 135 (02) 227-232
• 51 Cooper PC, Siddiq S, Morse C, Nightingale J, Mumford AD. Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution. Int J Lab Hematol 2011; 33 (05) 451-456